Chemotherapy dose scheduling via Q-learning in a Markov tumor model
Abstract
We describe a Q-learning approach to optimized chemotherapy dose scheduling in a stochastic finite-cell Markov process that models tumor cell natural selection dynamics. The three competing subpopulations comprising our virtual tumor are a chemo-sensitive population (S), and two chemo-resistant populations, R1 and R2, each resistant to one of two drugs, C1 and C2. The two drugs are toggled off or on which constitute the actions (selection pressure) imposed on our state-variables (S, R1, R2), measured as proportions in our finite state-space of N cancer cells (S + R1 + R2 = N). After the converged chemo-dosing policies are obtained, corresponding to a given reward structure, we focus on three important aspects of chemotherapy dose scheduling. First, we identify the most likely evolutionary paths of the tumor cell populations in response to the optimized (converged) policies. Second, we quantify the robustness in the ability to reach our target of balanced co-existence in light of incomplete information in both the initial cell-populations as well as the state-variables at each step. Third, we evaluate the efficacy of simplified policies which exploit the symmetries uncovered from an examination of the full policy. Our reward structure is designed to delay the onset of chemo-resistance in the tumor by rewarding a well-balanced mix of co-existing states, while punishing unbalanced subpopulations to avoid extinction.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- On the design of treatment schedules that avoid chemotherapeutic resistance
Y. Ma, P.K. Newton·bioRxiv·May 17, 2018
- Stochastic competitive release and adaptive chemotherapy
J. Park, P. K. Newton·bioRxiv·Jun 17, 2022
- Reinforcement learning derived chemotherapeutic schedules for robust patient-specific therapy
B. Eastman, M. Przedborski, M. Kohandel·bioRxiv·Apr 23, 2021
- A Mathematical Framework for Comparison of Intermittent and Continuous Adaptive Chemotherapy Dosing in Cancer
Cordelia D. McGehee, Yoichiro Mori A·npj Systems Biology and ApplicationsPeer-reviewed·Nov 29, 2024
- Are adaptive chemotherapy schedules robust? A three-strategy stochastic evolutionary game theory model
R. Dua, Y. Ma, P. K. Newton·bioRxiv·Feb 28, 2021
- The role of synergy and antagonism in designing multidrug adaptive chemotherapy schedules